EUVIMED · CrossrefZeitschrift
Alimentary Pharmacology & Therapeutics
ISSN 0269-2813 · Wiley
Neueste Artikel
Editorial: Not All Fibres Are Created Equal—Fibre Supplements for Personalised Application. Authors' Reply
Letter: Anticoagulation After Gastrointestinal Bleeding—Prognostic Associations are not Treatment Effects
Editorial: Microscopic Colitis—Are Medications Linked to Disease or Disease Investigation?
Editorial: When It Comes to Gastrointestinal Bleeding, It's Not the Anticoagulant Therapy Itself That's the Problem, but How It's Being Managed
Editorial: Objective Follow Up of Inflammation After Therapy for Eosinophilic Oesophagitis
Letter on: ‘Impact of Prior Biologic Mechanism of Action on Anti‐ TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study’
Letter on: ‘Impact of Prior Biologic Mechanism of Action on Anti‐ TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study’. Authors' Reply
Editorial: Therapeutic Drug Monitoring of Infliximab During Induction Therapy in IBD —Is This the Time for Model Informed Precision Dosing?
Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply
Clinical Trial: Capsule Sponge as a Non‐Endoscopic Monitoring Tool in Eosinophilic Oesophagitis—A Prospective Real–World Multicentre Study
Development of a Clinical and Biomarker‐Based Score to Predict Microscopic Colitis in Patients With Chronic Watery Diarrhoea
Letter: LGP2 Q425R In Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure. Authors' Reply
Impact of Prior Biologic Mechanism of Action on Anti‐ TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study
Clinical Trial: Randomised Placebo‐Controlled Trial of Methylcellulose and Psyllium Gels on Inulin‐Induced Colonic Gas
Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity. Authors' Reply
Letter: Temporal Misalignment and Selective Adjustment in PPI Risk Estimates After FMT
Baseline Clearance and Early Troughs Identify Candidates for Early Therapeutic Drug Monitoring During Infliximab Induction in Inflammatory Bowel Disease
Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC , Warfarin and Non‐Anticoagulated Patients
Incidence and Risk Factors for C. difficile Reinfection After Faecal Microbiota Transplantation or Antibiotic Therapy
Letter: LGP2 Q425R in Chronic Hepatitis Delta—Allele Dose, Hepatic Steatosis and Prior Interferon Exposure
Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Letter: The Q425R Variant in Chronic Hepatitis Delta—Distinguishing Cirrhosis Prevalence From Portal Hypertension Severity
Letter: The Risk and Outcomes of Gastrointestinal Bleeding in Patients Using Warfarin or Direct Oral Anticoagulants
Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma
Non‐Selective Beta‐Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation
A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection
Eosinophilic Oesophagitis Beyond the Oesophagus: High Prevalence of Chronic Rhinosinusitis‐Type Symptoms and Their Impact on Symptom Severity in Swiss EoE Cohort Study Patients
Natural History of Recurrent Acute Pancreatitis: Implications for Interventional Trial Design
Lowering the C‐Reactive Protein ( CRP ) Threshold Improves Risk Stratification in Acute Ulcerative Colitis: A Propensity‐Matched Analysis
Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety
Jahrgänge
2026 · 5052025 · 5942024 · 5712023 · 5002022 · 5562021 · 5252020 · 5882019 · 4932018 · 5692017 · 5122016 · 3982015 · 4242014 · 4592013 · 4332012 · 4382011 · 4002010 · 3492009 · 2902008 · 3102007 · 3812006 · 4922005 · 4252004 · 4732003 · 4052002 · 3192001 · 2642000 · 2761999 · 2741998 · 1771997 · 2031996 · 1761995 · 1101994 · 1021993 · 1111992 · 801991 · 891990 · 811989 · 711988 · 821987 · 66
EUVIMED